Blab Politics
Australia Sues 3M for $2 billion Over PFAS Contamination at Defence Bases
The Australian Commonwealth has filed its largest ever lawsuit, seeking A$2 billion in damages from American chemical maker 3M and its Australian subsidiary. The claim targets the cost of investigating and managing contamination from per‑ and polyfluoroalkyl substances (PFAS) that were released by firefighting foams used on almost 30 defence sites between the 1970s and the mid‑2000s.
PFAS, often called “forever chemicals,” are synthetic compounds that do not break down easily in the environment. The foams in question, known as aqueous film‑forming foams (AFFF), were widely used by the Australian Defence Force (ADF) to extinguish fires on bases and aircraft. The Commonwealth alleges that 3M withheld internal testing that showed the foams caused significant environmental damage.
The lawsuit, announced on 28 May 2026, is grounded in the Australian Consumer Law. The government claims 3M engaged in misleading or deceptive conduct by failing to disclose what it knew about the environmental risks of its foams. The claim seeks to recover past and future costs that the Commonwealth will incur while investigating and managing the contaminated sites, paying out class‑action settlements that have already totaled about A$400 million, and covering future remediation.
The case focuses exclusively on defence bases. It does not include state‑owned facilities such as public water utilities, nor does it address potential human‑health impacts. The Commonwealth has cited advice from health authorities that evidence of health effects from PFAS remains limited. While the World Health Organization identified one PFAS, PFOA, as carcinogenic in 2023, the agency is still reviewing other compounds.
3M has said it will defend itself against the claim. The company’s Australian building in a Sydney suburb was the site of the lawsuit’s filing. The lawsuit is the first time the Commonwealth has sought to recover costs from a private company for environmental contamination on defence property.
The legal strategy mirrors actions taken in the United States, where state attorneys‑general have pursued similar claims against manufacturers that marketed PFAS products as safe despite knowing their risks. In 2024, 3M reached a US settlement of A$14 billion (US$10 billion) to fund testing and treatment, while denying liability.
The Commonwealth’s claim may be settled before trial. Large lawsuits of this nature often resolve through settlement, allowing parties to agree on compensation without a judicial finding of liability. Australian courts encourage alternative dispute resolution, and all class actions against defence sites have settled before trial.
If the case proceeds to trial and the Commonwealth succeeds, it could open the door to further claims by fire services, water suppliers, and other groups affected by PFAS contamination. The lawsuit may also influence future litigation strategies in Australia and abroad.
The Commonwealth has not yet released the full court documents, but government statements and the court file indicate the claim is limited to environmental remediation costs. The case does not cover routine blood testing or long‑term medical monitoring for residents of communities such as Katherine in the Northern Territory, who have questioned whether a settlement would compensate losses not covered by earlier class actions.
The lawsuit also excludes other sites where PFAS contamination has been identified, such as industrial facilities and public water supplies. The Commonwealth has stated that the claim is focused on the 28 defence bases where the foams were used.
The outcome of the case remains uncertain. Settlement is possible, but the parties have maintained firm public positions. The Commonwealth’s next steps will involve court filings and potential negotiations. The legal process will determine whether the A$2 billion claim is upheld, reduced, or settled.
The case is part of a broader trend of legal action against PFAS manufacturers worldwide. In the United States, settlements have reached $18 billion by 2024. In Australia, the Commonwealth’s lawsuit represents a significant escalation in the government’s pursuit of remediation costs.
The lawsuit is scheduled to proceed through the Australian court system, with potential implications for environmental policy, corporate accountability, and the management of defence property. The Commonwealth will continue to monitor the case and may seek additional claims if the outcome is favorable.
The legal proceedings will unfold over the coming months, with the Commonwealth and 3M expected to present evidence and arguments. The case will be closely watched by environmental groups, defence communities, and the broader public concerned with PFAS contamination.
PFAS, often called “forever chemicals,” are synthetic compounds that do not break down easily in the environment. The foams in question, known as aqueous film‑forming foams (AFFF), were widely used by the Australian Defence Force (ADF) to extinguish fires on bases and aircraft. The Commonwealth alleges that 3M withheld internal testing that showed the foams caused significant environmental damage.
The lawsuit, announced on 28 May 2026, is grounded in the Australian Consumer Law. The government claims 3M engaged in misleading or deceptive conduct by failing to disclose what it knew about the environmental risks of its foams. The claim seeks to recover past and future costs that the Commonwealth will incur while investigating and managing the contaminated sites, paying out class‑action settlements that have already totaled about A$400 million, and covering future remediation.
The case focuses exclusively on defence bases. It does not include state‑owned facilities such as public water utilities, nor does it address potential human‑health impacts. The Commonwealth has cited advice from health authorities that evidence of health effects from PFAS remains limited. While the World Health Organization identified one PFAS, PFOA, as carcinogenic in 2023, the agency is still reviewing other compounds.
3M has said it will defend itself against the claim. The company’s Australian building in a Sydney suburb was the site of the lawsuit’s filing. The lawsuit is the first time the Commonwealth has sought to recover costs from a private company for environmental contamination on defence property.
The legal strategy mirrors actions taken in the United States, where state attorneys‑general have pursued similar claims against manufacturers that marketed PFAS products as safe despite knowing their risks. In 2024, 3M reached a US settlement of A$14 billion (US$10 billion) to fund testing and treatment, while denying liability.
The Commonwealth’s claim may be settled before trial. Large lawsuits of this nature often resolve through settlement, allowing parties to agree on compensation without a judicial finding of liability. Australian courts encourage alternative dispute resolution, and all class actions against defence sites have settled before trial.
If the case proceeds to trial and the Commonwealth succeeds, it could open the door to further claims by fire services, water suppliers, and other groups affected by PFAS contamination. The lawsuit may also influence future litigation strategies in Australia and abroad.
The Commonwealth has not yet released the full court documents, but government statements and the court file indicate the claim is limited to environmental remediation costs. The case does not cover routine blood testing or long‑term medical monitoring for residents of communities such as Katherine in the Northern Territory, who have questioned whether a settlement would compensate losses not covered by earlier class actions.
The lawsuit also excludes other sites where PFAS contamination has been identified, such as industrial facilities and public water supplies. The Commonwealth has stated that the claim is focused on the 28 defence bases where the foams were used.
The outcome of the case remains uncertain. Settlement is possible, but the parties have maintained firm public positions. The Commonwealth’s next steps will involve court filings and potential negotiations. The legal process will determine whether the A$2 billion claim is upheld, reduced, or settled.
The case is part of a broader trend of legal action against PFAS manufacturers worldwide. In the United States, settlements have reached $18 billion by 2024. In Australia, the Commonwealth’s lawsuit represents a significant escalation in the government’s pursuit of remediation costs.
The lawsuit is scheduled to proceed through the Australian court system, with potential implications for environmental policy, corporate accountability, and the management of defence property. The Commonwealth will continue to monitor the case and may seek additional claims if the outcome is favorable.
The legal proceedings will unfold over the coming months, with the Commonwealth and 3M expected to present evidence and arguments. The case will be closely watched by environmental groups, defence communities, and the broader public concerned with PFAS contamination.
